Irish Examiner on MSN17d
MSD acquires WuXi's vaccine facility in Dundalk for €500m
The Dundalk site was WuXi's first manufacturing investment in Europe and the company’s first investment of this scale outside of China ...
Hosted on MSN16d
WuXi Biologics to sell Ireland-based vaccine site to MSD for $500m
WuXi Biologics subsidiary WuXi Vaccines has agreed to sell its vaccine manufacturing facility in Dundalk, Ireland, to MSD for approximately $500m. Expected to close in the first half of 2025, the deal ...
Dundalk Democrat12d
MSD Ireland acquisition of WuXi plant in Dundalk welcomed
News that pharmaceutical company MSD Ireland has acquired the WuXi Vaccines manufacturing facility in Dundalk has been ...
SiliconRepublic17d
MSD to acquire WuXi Vaccines’ Dundalk site, and plans 1,000 jobs in coming years
Laura Varley is a Careers reporter at Silicon Republic. She has a background in technology PR and journalism and is borderline obsessed with film and television, the theatre, Marvel and Mayo GAA ...
pharmaphorum1y
MSD gives warning to UK ahead of $1.3bn facility work
MSD has expanded its presence in Ireland with an agreement to buy a vaccines manufacturing facility from WuXi Biologics in Dundalk. Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm ...
Yahoo Finance16d
WuXi Biologics to sell Ireland-based vaccine site to MSD for $500m
WuXi Biologics subsidiary WuXi Vaccines has agreed to sell its vaccine manufacturing facility in Dundalk, Ireland, to MSD for approximately $500m. Expected to close in the first half of 2025 ...